The GATRA is a program whose aim is to identify and support innovative clinical and scientific research aimed at gaining more insight into the current and new uses of Antithrombin.
By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care

Applications for Gatra 2023 will be accepted until May 31, 2023.

Please click here to apply.

To see the 2022 GATRA Award winner please click here.